IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL I
Business in Brief - Business - Haaretz.com
One, two, three, gone: Teva loses third patent on new Copaxone formula | Fierce Pharma
Synthon says EPO appeal board has revoked Copaxone API patent
Teva may move court against Dr Reddy's for patent infringement - The Economic Times
US Court rules in favour of Mylan for Copaxone patents: Natco, Health News, ET HealthWorld
Natco's partner Mylan prevails over Teva in Copaxone patent litigation
RRMS High-dose Therapy, Synthon's Generic Version of Copaxone, Wins EU Approval
Teva's patent failure gives long-acting Copaxone generics free rein | Fierce Pharma
PTAB invalidates three patents covering Teva's Copaxone, opens door for Mylan's generic version - IPWatchdog.com | Patents & Patent Law
Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL
Teva's Stock Drops After Approval of Copaxone Competitors | Ctech
Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Mylan wins us district court ruling related to copaxone 40 mg/ml patents
Mylan Wins UK Court Ruling Related to Copaxone® 40 mg/mL Patent | Mylan N.V.
With patent strikedown, Teva's new Copaxone formula loses two defenses against generics | Fierce Pharma
NATCO: US Court rules in favour of Mylan for Copaxone patents: Natco - The Economic Times
Synthon's generic version of Copaxone 40mg approved in Europe
Teva Makes Headway in European Copaxone Patent Case | Ctech
EPO destroys Teva copaxone patent after appeal - JUVE Patent
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere | Fierce Pharma
Rx Item-Copaxone 20Mg/Ml Syringe 30X1 Ml By Teva Pharma Refrigerated
Natco Pharma upbeat over US Patent Office's ruling on two of Copaxone patents | Business Standard News
US PTO rules in Mylan's favour, invalidates Teva patent: Natco, Health News, ET HealthWorld
Teva loses U.S. patent appeal for 40mg version of Copaxone - Business - Haaretz.com
High Court Sides With Teva In Patent Dispute
